The problem of patenting of human genes, which was discussed at the Workshop organized by OECD, has become
very actual due to granted patents that concern testing of genetic disposition for breast cancer. Companies that had
made large investments into this research clearly support patenting of their discoveries. But such patents can reduce
general accessibility of genetic testing. Existing laws, and namely the Directive of the European Council unfortunately
are not unambiguous and allow rather free explanation.
DNA diagnostics, genetic testing, patenting, licensing, intellectual property rights.